Inspire And Kirin Enter Diagnostics Collaboration

Inspire Pharmaceuticals, Inc. announced a licensing agreement with Kirin Brewery Co., Ltd., of Tokyo, Japan, in which Kirin’s Pharmaceutical Division has obtained rights to develop and commercialise Inspire’s lung-disease diagnostic adjunct product, INS316 Diagnostic, in twenty- one Asian countries and regions including Japan. The initial indication for INS316 will be to aid in the diagnosis Read more about Inspire And Kirin Enter Diagnostics Collaboration[…]

Dendreon Corporation Completes Acquisition Of Corvas International

Dendreon Corporation has announced that it has completed its acquisition of Corvas International. The acquisition provides Dendreon with an enhanced product pipeline and the financial position to discover, develop and commercialize innovative therapeutic products in oncology. “This is a very exciting time for Dendreon, our stockholders and the many cancer patients who could potentially benefit Read more about Dendreon Corporation Completes Acquisition Of Corvas International[…]